Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,736,851,118
+$829,626,456 QoQ
Shares Held
22,588,696
+12.5% QoQ
Ownership
0.937%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#14
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. JNJ ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,736,851,118 | 22,588,696 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,907,224,662 | 20,075,375 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,809,184,394 | 23,238,388 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,789,913,506 | 25,832,777 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,799,891,178 | 24,876,538 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,755,606,167 | 22,645,961 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,522,447,438 | 24,356,572 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,877,344,973 | 23,925,367 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,631,983,184 | 24,849,365 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,756,532,865 | 23,746,968 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,764,851,694 | 24,019,725 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $3,212,821,588 | 20,628,068 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,799,650,634 | 22,955,840 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,934,950,125 | 25,386,775 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,745,016,669 | 26,861,119 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,571,946,352 | 27,986,939 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,242,094,312 | 29,531,262 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,808,286,830 | 32,772,594 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,561,017,650 | 32,507,264 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,208,462,370 | 32,250,541 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,425,675,323 | 32,934,778 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,569,190,722 | 33,886,162 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,575,063,268 | 35,424,217 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,028,053,220 | 33,772,523 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,045,924,394 | 28,769,995 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,006,895,084 | 30,556,662 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||